Lawrence D. True

Active 1988–2026

152
Papers
33,461
Citations
86
h-index
143
i10-index

Citations

Citations per year for Lawrence D. True1978: 1 citations1990: 1 citations1991: 3 citations1992: 3 citations1993: 1 citations1994: 3 citations1995: 6 citations1996: 2 citations1997: 6 citations1998: 10 citations1999: 13 citations2000: 32 citations2001: 44 citations2002: 62 citations2003: 89 citations2004: 102 citations2005: 94 citations2006: 91 citations2007: 104 citations2008: 159 citations2009: 146 citations2010: 231 citations2011: 310 citations2012: 283 citations2013: 316 citations2014: 290 citations2015: 289 citations2016: 353 citations2017: 401 citations2018: 485 citations2019: 1,169 citations2020: 1,375 citations2021: 1,380 citations2022: 1,120 citations2023: 863 citations2024: 1,372 citations2025: 625 citations2026: 24 citations1979–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,012 citing papers, 32.1% of this breakdownChina: 1,575 citing papers, 10.1% of this breakdownUnited Kingdom: 1,030 citing papers, 6.6% of this breakdownCanada: 847 citing papers, 5.4% of this breakdownGermany: 673 citing papers, 4.3% of this breakdownItaly: 645 citing papers, 4.1% of this breakdownAustralia: 472 citing papers, 3% of this breakdownFrance: 439 citing papers, 2.8% of this breakdownJapan: 417 citing papers, 2.7% of this breakdownSpain: 387 citing papers, 2.5% of this breakdownNetherlands: 370 citing papers, 2.4% of this breakdownSwitzerland: 339 citing papers, 2.2% of this breakdown
0%32.1%Other 21.8%

Fields

  • Medicine55.7%
  • Biochemistry, Genetics and Molecular Biology37%
  • Computer Science1.7%
  • Immunology and Microbiology1.6%
  • Engineering1.3%
  • Materials Science0.7%
  • Other2%

Topics

  • Prostate Cancer Treatment and Research11.6%
  • Prostate Cancer Diagnosis and Treatment4.8%
  • Cancer Genomics and Diagnostics3.7%
  • Cancer, Lipids, and Metabolism1.9%
  • Epigenetics and DNA Methylation1.9%
  • Ubiquitin and proteasome pathways1.8%
  • Other74.3%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. The landscape of somatic copy-number alteration across human cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth A. Maher, Frederic J. Kaye, Hidefumi Sasaki, Joel E. Tepper, Jonathan A. Fletcher, Josep Tabernero, José Baselga, Ming‐Sound Tsao, Francesca Demichelis, Mark A. Rubin, Pasi A. Jänne, Mark J. Daly, Carmelo Nucera, Ross L. Levine, Benjamin L. Ebert, Stacey Gabriel, Anil K. Rustgi, Cristina R. Antonescu, Marc Ladanyi, Anthony Letai, Levi A. Garraway, Massimo Loda, David G. Beer, Lawrence D. True, Aikou Okamoto, Scott L. Pomeroy, Samuel Singer, Todd R. Golub, Eric S. Lander, Gad Getz, William R. Sellers, Matthew Meyerson - Nature 2010 cited by 4,185

  3. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Small - Journal of Clinical Oncology 2018 cited by 812

  4. Genomic and phenotypic heterogeneity in prostate cancer

    Authors: , , , , , , , , - Nature Reviews Urology 2020 cited by 511

  5. Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 756

  6. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 468

  7. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

    Authors: , , , , , , , - Nature Medicine 2012 cited by 784

  8. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 763

  9. Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling

    Authors: , , , , , , , , , , , , , , - Nature Communications 2021 cited by 298

  10. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 122

  11. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 393

  12. A hybrid open-top light-sheet microscope for versatile multi-scale imaging of cleared tissues

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hu Zhao, Lawrence D. True, R. Clay Reid, Jayaram Chandrashekar, Hiroki R. Ueda, Karel Svoboda, Jonathan Liu - Nature Methods 2022 cited by 177

  13. Light-sheet microscopy for slide-free non-destructive pathology of large clinical specimens

    Authors: , , , , , , , , - Nature Biomedical Engineering 2017 cited by 430

  14. Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease

    Authors: , , , , , , , , , , , - Cancer Research 2009 cited by 409

  15. LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics

    Authors: , , , , , , , , , , , , , - The Prostate 2017 cited by 314

  16. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Magi‐Galluzzi, Rohit Mehra, Santosh Menon, Hiroshi Miyamoto, Rodolfo Montironi, George J. Netto, Jane Nguyen, Adeboye O. Osunkoya, Anil V. Parwani, Brian D. Robinson, Mark A. Rubin, Rajal B. Shah, Jeffrey So, Hiroyuki Takahashi, Fabio Tavora, Maria Tretiakova, Lawrence D. True, Sara E. Wobker, Ximing J. Yang, Ming Zhou, Debra L. Zynger, Kiril Trpkov - Archives of Pathology & Laboratory Medicine 2020 cited by 276

  17. Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2023 cited by 82

  18. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  19. Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning–Assisted Gland Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 108

  20. Analysis of 3D pathology samples using weakly supervised AI

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2024 cited by 104

  21. Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

    Authors: , , , , , , , - Cancer Research 2008 cited by 1,412

  22. Harnessing non-destructive 3D pathology

    Authors: , , , , , , - Nature Biomedical Engineering 2021 cited by 169

  23. The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis

    Authors: , , , , , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 493

  24. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiu Rao, Victor E. Reuter, Rola Saleeb, Rajal B. Shah, Steven C. Smith, Satish K. Tickoo, Maria Tretiakova, Lawrence D. True, Virginie Verkarre, Sara E. Wobker, Ming Zhou, Ondřej Hes - Modern Pathology 2021 cited by 220